Quinoline-derived amide modulators of vanilloid VR1 receptor
申请人:——
公开号:US20040192728A1
公开(公告)日:2004-09-30
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR
申请人:Codd Ellen
公开号:US20080300236A1
公开(公告)日:2008-12-04
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to quinoline-derived amides that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
An optical device comprising a first electrode for injecting charge carriers of a first polarity, a second electrode for injecting charge carriers of a second polarity, and a layer of semiconductive solvent processable polymer disposed between the first and second electrodes, the layer of semiconductive polymer comprising a blend of a first charge transporting and/or electroluminescent polymer and a second charge transporting and/or electroluminescent polymer, wherein at least the first polymer is cross-linked.